. Representative blood analysis to determine donor chimerism. A) Representative blood analysis of recipient mice. After gating based on size and granularity, single cells are gated on based on CD45 expression. Within CD45+ fraction, macrophages, granulocytes, T cells, and B cells can be identified as distinct populations. Macrophages are defined as CD45+ Mac-1+ Gr1-, granulocytes as CD45+ Mac-1+ Gr1+, T cells as CD45+ CD3+, and B cells as CD45+ CD19+. B) Representative analysis of T cells for donor chimerism. CFP and Tomato expression can be detected in AmCyan and PE channels, respectively. "Host" cells are defined by the lack of CFP/Tomato expression. Donor chimerism within each cell type is analyzed similarly. Figure S2 . Lineage output from CD11a-EPCR+ KLS and CD11a+ KLS in competitively transplanted recipients. A) Lineage distribution of granulocytes (Mac-1+ Gr1+), Macrophages (Mac-1+ Gr1-) T cells (CD3+) and B cells (CD19+) in the peripheral blood of recipients from CD11a-EPCR+ (green) or CD11a+ (orange) KLS cells 12 weeks posttransplant, and in non-transplanted controls (n=4, error bars SD). B) Ratio of myeloid to lymphoid cells. Myeloid cells are defined as CD45+, Mac-1+ or Gr1+, and lymphoid cells as CD45+, CD3+ or CD19+. CD11a-EPCR+ KLS cells show similar lineage distribution and myeloid/lymphoid ratios as the non-transplanted control, indicating they can reconstitute peripheral immune cells at physiologic ratios, indicative of HSCs. Conversely, CD11a+ KLS cells show a distinct B lineage bias and skewed myeloid/lymphoid ratios, suggesting they are more differentiated than HSCs.
CD11a/EPCR and CD48/CD150 plots are gated on live, singlet, non-autofluorescent, Ter119-cells. Plots in the black boxes are gated on either CD11a-EPCR+ (top row) or CD150+ CD48-(bottom row). Percentages of cells in each gate are listed as the average of two animals ± SD. FACS plots are representative of two independent experiments. B) Sorting strategy using only CD150 and CD48 as HSC markers. CFP+ CD150+ CD48-and Tomato+ "Not SLAM" (not CD150+ CD48-) cells (and vice versa) were sorted and co-transplanted in a competitive setting and at the physiological ratios shown. Approximately 750 CD150+ CD48-and 500,000 "Not SLAM" were transplanted into each recipient. C) Time-course analysis of blood granulocyte chimerism from CD150+ CD48-and "Not SLAM" sources in primary recipients 4, 9, 13, and 17 weeks (W) post-transplant. D) Figure S4 . Comparison of total blood chimerism and lineage output between two-color sorting methods. A) Time-course analysis of total blood chimerism from CD11a-EPCR+ and CD150+ CD48-sources in primary recipients 4, 9, and 12 weeks posttransplant, and in secondary recipients (separated by dashed line) at week 6 following secondary transplant. B) Lineage output analysis from CD11a-EPCR+ and CD150+ CD48-sources. Granulocyte (i), macrophage (ii), T cell (iii), and B cell (iv) lineage output are shown from donor sources over time (n=8, error bars SD). C) Time-course analysis of total blood (i), blood macrophage (ii), T cell (iii), and B cell (iv) chimerism from "Not 11a/EPCR" and "Not SLAM" sources in primary recipients 4, 9, and 12 weeks post-transplant. 
